fda warning compounded tirzepatide Eli Lilly has filed lawsuits against compounders selling unapproved versions of its weight-loss drugs, Mounjaro and Zepbound. With the reinforcing its stance, offering may carry serious legal risks. Are US FDA sends 25 letters

To protect your study results and ensure financial security, avoid consumer retail alternatives such as bpc 157 capsules , cosmetic bpc 157 nasal spray pumps, or unverified marketplace listings

The purpose of the present investigation was to generate the first safety, pharmacokinetic and pharmacodynamic data for oral semaglutide in healthy subjects and subjects with T2D

In an underreported countermove, a federal antitrust lawsuit was filed on January 14, 2026, alleging that Eli Lilly and Novo Nordisk engaged in coordinated exclusionary conduct to suppress lawful compounded GLP-1 access

The experiment was conducted over 24 weeks, followed by a four-week washout period for further data collection and participant monitoring

Research indicates that it reduces the risk of kidney disease progression by up to 24%, lowering the chances of severe outcomes like dialysis, kidney transplant, or kidney failure